Watson Pharmaceuticals

(

WPI

) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day down 0.4%. By the end of trading, Watson Pharmaceuticals fell $1.17 (-1.6%) to $71.29 on average volume. Throughout the day, 2.1 million shares of Watson Pharmaceuticals exchanged hands as compared to its average daily volume of 2.3 million shares. The stock ranged in price between $71.21-$72.67 after having opened the day at $72.67 as compared to the previous trading day's close of $72.46. Other company's within the Health Care sector that declined today were:

Chelsea Therapeutics International

(

CHTP

), down 31.3%,

ARCA biopharma

(

ABIO

), down 21.7%,

Cormedix

(

CRMD

), down 17.4%, and

Sunshine Heart

(

SSH

), down 16.5%.

Watson Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, marketing, sale, and distribution of generic and brand pharmaceutical products in the United States, western Europe, Canada, Australasia, Asia, South America, and South Africa. Watson Pharmaceuticals has a market cap of $9.39 billion and is part of the

drugs

industry. The company has a P/E ratio of 34.6, above the average drugs industry P/E ratio of 34.4 and above the S&P 500 P/E ratio of 17.7. Shares are up 22.1% year to date as of the close of trading on Wednesday. Currently there are 16 analysts that rate Watson Pharmaceuticals a buy, no analysts rate it a sell, and five rate it a hold.

TheStreet Ratings rates Watson Pharmaceuticals as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the positive front,

Prima Biomed Ltd. ADR

(

PBMD

), up 23.5%,

Synta Pharmaceuticals

(

SNTA

), up 15.6%,

Theragenics Corporation

(

TGX

), up 15%, and

Chemocentryx

(

CCXI

), up 14.9%, were all gainers within the health care sector with

GlaxoSmithKline

(

GSK

) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).

null